Teleflex Inc. Files Q3 2024 10-Q Report

Ticker: TFX · Form: 10-Q · Filed: Oct 31, 2024 · CIK: 96943

Teleflex Inc 10-Q Filing Summary
FieldDetail
CompanyTeleflex Inc (TFX)
Form Type10-Q
Filed DateOct 31, 2024
Risk Levelmedium
Pages16
Reading Time19 min
Key Dollar Amounts$1.00
Sentimentneutral

Sentiment: neutral

Topics: 10-Q, financials, quarterly-report

Related Tickers: TFLEX

TL;DR

Teleflex Q3 2024 10-Q is in. Check financials.

AI Summary

Teleflex Inc. filed its 10-Q for the period ending September 29, 2024. The filing covers the third quarter of 2024, detailing financial performance and operational updates. Specific financial figures and operational details for the quarter and year-to-date periods are presented.

Why It Matters

This filing provides investors and analysts with the latest financial results and operational insights for Teleflex Inc., crucial for understanding the company's current performance and future outlook.

Risk Assessment

Risk Level: medium — 10-Q filings inherently carry medium risk due to the detailed financial and operational information that can impact stock price.

Key Numbers

  • 2024 Q3 — Reporting Period (Third quarter of 2024 financial performance)
  • 2024-09-29 — Period End Date (End of the reporting period for financial data)
  • 2024-10-31 — Filing Date (Date the report was submitted to the SEC)

Key Players & Entities

  • TELEFLEX INC (company) — Filer
  • 20240929 (date) — Reporting Period End Date
  • 20241031 (date) — Filing Date
  • WAYNE, PA (location) — Company Headquarters

FAQ

What is the reporting period for this 10-Q filing?

The reporting period for this 10-Q filing is the period ending September 29, 2024.

When was this 10-Q filed with the SEC?

This 10-Q was filed on October 31, 2024.

What is the company's primary business classification?

The company is classified under 'SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]'.

Where is Teleflex Inc. headquartered?

Teleflex Inc. is headquartered at 550 E SWEDESFORD RD, SUITE 400, WAYNE, PA 19087.

What fiscal year end does Teleflex Inc. report?

Teleflex Inc. reports a fiscal year end of December 31.

Filing Stats: 4,661 words · 19 min read · ~16 pages · Grade level 19.8 · Accepted 2024-10-31 11:38:17

Key Financial Figures

  • $1.00 — ich registered Common Stock, par value $1.00 per share TFX New York Stock Exchange

Filing Documents

— FINANCIAL INFORMATION

PART I — FINANCIAL INFORMATION

: Financial Statements (Unaudited)

Item 1: Financial Statements (Unaudited): 2 Condensed Consolidated Statements of Income 2 Condensed Consolidated Statements of Comprehensive Income 3 Condensed Consolidated Balance Sheets 4 Condensed Consolidated Statements of Cash Flows 5 Condensed Consolidated Statements of Changes in Equity 6 Notes to Condensed Consolidated Financial Statements 7

: Management's Discussion and Analysis of Financial Condition and Results of Operations

Item 2: Management's Discussion and Analysis of Financial Condition and Results of Operations 22

: Quantitative and Qualitative Disclosures About Market Risk

Item 3: Quantitative and Qualitative Disclosures About Market Risk 31

: Controls and Procedures

Item 4: Controls and Procedures 31

— OTHER INFORMATION

PART II — OTHER INFORMATION

: Legal Proceedings

Item 1: Legal Proceedings 32

: Risk Factors

Item 1A: Risk Factors 32

: Unregistered Sales of Equity Securities and Use of Proceeds

Item 2: Unregistered Sales of Equity Securities and Use of Proceeds 32

: Defaults Upon Senior Securities

Item 3: Defaults Upon Senior Securities 32

: Mine Safety Disclosures

Item 4: Mine Safety Disclosures 32

: Other Information

Item 5: Other Information 33

: Exhibits

Item 6: Exhibits 34

— FINANCIAL INFORMATION

PART I — FINANCIAL INFORMATION

Financial Statements

Item 1. Financial Statements TELEFLEX INCORPORATED CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited) Three Months Ended Nine Months Ended September 29, 2024 October 1, 2023 September 29, 2024 October 1, 2023 (Dollars and shares in thousands, except per share) Net revenues $ 764,375 $ 746,389 $ 2,251,915 $ 2,200,580 Cost of goods sold 334,203 330,078 989,151 985,066 Gross profit 430,172 416,311 1,262,764 1,215,514 Selling, general and administrative expenses 247,257 213,194 740,718 669,216 Research and development expenses 38,726 37,576 117,119 118,493 Pension settlement (benefit) charge ( 5,407 ) — 132,732 — Restructuring and impairment charges 285 231 10,799 3,960 Income from continuing operations before interest and taxes 149,311 165,310 261,396 423,845 Interest expense 21,058 23,192 64,909 59,291 Interest income ( 2,298 ) ( 7,487 ) ( 5,751 ) ( 9,486 ) Income from continuing operations before taxes 130,551 149,605 202,238 374,040 Taxes (benefit) on income from continuing operations 19,633 11,935 ( 4,586 ) 47,651 Income from continuing operations 110,918 137,670 206,824 326,389 Operating income (loss) from discontinued operations 112 ( 687 ) ( 639 ) ( 1,512 ) Taxes (benefit) on operating loss from discontinued operations 26 ( 157 ) ( 146 ) ( 346 ) Income (loss) from discontinued operations 86 ( 530 ) ( 493 ) ( 1,166 ) Net income $ 111,004 $ 137,140 $ 206,331 $ 325,223 Earnings per share: Basic: Income from continuing operations $ 2.37 $ 2.93 $ 4.40 $ 6.95 Income (loss) from discontinued operations 0.01 ( 0.01 ) ( 0.01 ) ( 0.03 ) Net income $ 2.38 $ 2.92 $ 4.39 $ 6.92 Diluted: Income from continuing operations $ 2.36 $ 2.91 $ 4.38 $ 6.90 Loss from discontinued operations — ( 0.01 ) ( 0.01 ) ( 0.02 ) Net income $ 2.36 $ 2.90 $ 4.37 $ 6.88 Weighted average common shares outstanding Basic 46,724 46,992 46,995 46,974 Diluted 47,012 47,299 47,256 47,304 The accompanying notes are an integral part of the condensed consolidat

View Full Filing

View this 10-Q filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.